{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:03:13Z","timestamp":1793124193809,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024GH-ZDXM-39"],"award-info":[{"award-number":["2024GH-ZDXM-39"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03849-4","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:04:39Z","timestamp":1748678679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Global insight of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal trends and health inequalities analyses"],"prefix":"10.1186","volume":"23","author":[{"given":"Xingyang","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"3849_CR1","doi-asserted-by":"publisher","first-page":"1119374","DOI":"10.3389\/fpubh.2023.1119374","volume":"11","author":"Y-Q Tian","year":"2023","unstructured":"Tian Y-Q, Yang J-C, Hu J-J, Ding R, Ye D-W, Shang J-W. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the global burden of disease study 2019. Front Public Health. 2023;11:1119374.","journal-title":"Front Public Health."},{"key":"3849_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2024;74:229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40779-021-00354-z","volume":"8","author":"H Zi","year":"2021","unstructured":"Zi H, He S-H, Leng X-Y, Xu X-F, Huang Q, Weng H, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990\u20132019. Military Med Res. 2021;8:60.","journal-title":"Military Med Res."},{"key":"3849_CR4","first-page":"939","volume":"10","author":"EA Guancial","year":"2015","unstructured":"Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, et al. Bladder cancer in the elderly patient: Challenges and solutions. Clinical Interventions in Aging. 2015;10:939\u201349.","journal-title":"Clinical Interventions in Aging."},{"key":"3849_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrurol.2014.91","volume":"11","author":"CA Salinas","year":"2014","unstructured":"Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Prostate cancer in young men: An important clinical entity. Nature Reviews Urology. 2014;11:317\u201323.","journal-title":"Nature Reviews Urology."},{"key":"3849_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82:529\u201342.","journal-title":"Eur Urol."},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","volume":"4","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: Analysis of a population-based cancer registry. The Lancet Public Health. 2019;4:e137-47.","journal-title":"The Lancet Public Health."},{"key":"3849_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee H-Y, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nature Reviews Clinical Oncology. 2022;19:656\u201373.","journal-title":"Nature Reviews Clinical Oncology."},{"key":"3849_CR9","doi-asserted-by":"crossref","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: A systematic analysis for the global burden of disease study 2021. Lancet (London, England). 2024;403:2162\u2013203.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"3849_CR10","doi-asserted-by":"crossref","unstructured":"Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. bmjonc. 2023;2:e000049.","DOI":"10.1136\/bmjonc-2023-000049"},{"key":"3849_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13045-024-01623-9","volume":"17","author":"W Li","year":"2024","unstructured":"Li W, Liang H, Wang W, Liu J, Liu X, Lao S, et al. Global cancer statistics for adolescents and young adults: population based study. J Hematol Oncol. 2024;17:99.","journal-title":"J Hematol Oncol."},{"key":"3849_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.soncn.2014.11.006","volume":"31","author":"P Patterson","year":"2015","unstructured":"Patterson P, McDonald FEJ, Zebrack B, Medlow S. Emerging issues among adolescent and young adult cancer survivors. Semin Oncol Nurs. 2015;31:53\u20139.","journal-title":"Semin Oncol Nurs."},{"key":"3849_CR13","doi-asserted-by":"crossref","unstructured":"Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, et al. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2023;21:851\u201380.","DOI":"10.6004\/jnccn.2023.0040"},{"key":"3849_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1001\/jamaoncol.2022.6132","volume":"9","author":"I Turgeman","year":"2023","unstructured":"Turgeman I, West HJ. Adolescents and young adults with cancer. JAMA oncology. 2023;9:440.","journal-title":"JAMA oncology."},{"key":"3849_CR15","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/JS9.0000000000001054","volume":"110","author":"Z Li","year":"2024","unstructured":"Li Z, Zhang X, Sun C, Li Z, Fei H, Zhao D. Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15\u201349 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study. International Journal of Surgery (London, England). 2024;110:1929\u201340.","journal-title":"International Journal of Surgery (London, England)."},{"key":"3849_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100096","volume":"6","author":"A Ferrari","year":"2021","unstructured":"Ferrari A, Stark D, Peccatori FA, Fern L, Laurence V, Gaspar N, et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE). ESMO Open. 2021;6: 100096.","journal-title":"ESMO Open."},{"key":"3849_CR17","doi-asserted-by":"publisher","first-page":"04205","DOI":"10.7189\/jogh.14.04205","volume":"14","author":"J Chen","year":"2024","unstructured":"Chen J, Dalerba P, Terry MB, Yang W. Global obesity epidemic and rising incidence of early-onset cancers. Journal of Global Health. 2024;14:04205.","journal-title":"Journal of Global Health."},{"key":"3849_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi H, Liu M-Y, Luo L-S, Huang Q, Luo P-C, Luan H-H, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Military Medical Research. 2024;11:64.","journal-title":"Military Medical Research."},{"key":"3849_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/CAD.0000000000000405","volume":"27","author":"C Messina","year":"2016","unstructured":"Messina C, Buzzatti G, Dellepiane C, Cavo A, Tolomeo F, Cattrini C, et al. Genitourinary tumours in the targeted therapies era: New advances in clinical practice and future perspectives. Anticancer Drugs. 2016;27:917\u201343.","journal-title":"Anticancer Drugs."},{"key":"3849_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-017-0457-4","volume":"10","author":"K Mehta","year":"2017","unstructured":"Mehta K, Patel K, Parikh RA. Immunotherapy in genitourinary malignancies. J Hematol Oncol. 2017;10:95.","journal-title":"J Hematol Oncol."},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-023-01511-8","volume":"16","author":"Q Qin","year":"2023","unstructured":"Qin Q, Sheffield H, Taasan SM, Wang AZ, Zhang T. Genitourinary cancers updates: Highlights from ASCO 2023. J Hematol Oncol. 2023;16:112.","journal-title":"J Hematol Oncol."},{"key":"3849_CR22","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/2159-8290.CD-22-1441","volume":"13","author":"F Facchinetti","year":"2023","unstructured":"Facchinetti F, Hollebecque A, Braye F, Vasseur D, Pradat Y, Bahleda R, et al. Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer. Cancer Discov. 2023;13:1998\u20132011.","journal-title":"Cancer Discov."},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/cancers13030546","volume":"13","author":"V Mollica","year":"2021","unstructured":"Mollica V, Rizzo A, Rosellini M, Marchetti A, Ricci AD, Cimadamore A, et al. Bone targeting agents in patients with metastatic prostate cancer: State of the art. Cancers (Basel). 2021;13:546.","journal-title":"Cancers (Basel)."},{"key":"3849_CR24","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.3390\/cancers16213689","volume":"16","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Ayasun R, Rizzo A, Guven DC. Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: A systematic review and meta-analysis. Cancers (Basel). 2024;16:3689.","journal-title":"Cancers (Basel)."},{"key":"3849_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.euf.2021.01.003","volume":"8","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Mollica V, Massari F. Expression of programmed cell death ligand 1 as a predictive biomarker in metastatic urothelial carcinoma patients treated with first-line immune checkpoint inhibitors versus chemotherapy: A systematic review and meta-analysis. Eur Urol Focus. 2022;8:152\u20139.","journal-title":"Eur Urol Focus."},{"key":"3849_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.euf.2021.03.001","volume":"8","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Mollica V, Santoni M, Ricci AD, Rosellini M, Marchetti A, et al. Impact of clinicopathological features on survival in patients treated with first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors for renal cell carcinoma: A meta-analysis of randomized clinical trials. Eur Urol Focus. 2022;8:514\u201321.","journal-title":"Eur Urol Focus."},{"key":"3849_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.euo.2023.07.003","volume":"7","author":"M Santoni","year":"2024","unstructured":"Santoni M, Buti S, Myint ZW, Maruzzo M, Iacovelli R, Pichler M, et al. Real-world outcome of patients with advanced renal cell carcinoma and intermediate- or poor-risk international metastatic renal cell carcinoma database consortium criteria treated by immune-oncology combinations: Differential effectiveness by risk group? Eur Urol Oncol. 2024;7:102\u201311.","journal-title":"Eur Urol Oncol."},{"key":"3849_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41591-021-01600-6","volume":"28","author":"T Powles","year":"2022","unstructured":"Powles T, Yuen KC, Gillessen S, Kadel EE, Rathkopf D, Matsubara N, et al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: A randomized phase 3 trial. Nat Med. 2022;28:144\u201353.","journal-title":"Nat Med."},{"key":"3849_CR29","doi-asserted-by":"crossref","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the global burden of disease study 2021. Lancet (London, England). 2024;403:2133\u201361.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"key":"3849_CR30","doi-asserted-by":"crossref","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the global burden of disease study 2021. Lancet (London, England). 2024;403:2100\u201332.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"3849_CR31","doi-asserted-by":"crossref","unstructured":"GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis for the global burden of disease study 2021. Lancet (London, England). 2024;403:1989\u20132056.","DOI":"10.1016\/S0140-6736(24)00476-8"},{"key":"3849_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102829","volume":"76","author":"Z Luo","year":"2024","unstructured":"Luo Z, Shan S, Cao J, Zhou J, Zhou L, Jiang D, et al. Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: A secondary analysis of the global burden of disease study 2021. EClinicalMedicine. 2024;76: 102829.","journal-title":"EClinicalMedicine."},{"key":"3849_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7\u201330.","journal-title":"CA Cancer J Clin."},{"key":"3849_CR34","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1097\/JS9.0000000000001603","volume":"110","author":"X Zhou","year":"2024","unstructured":"Zhou X, Zhang Z, Ruan C, Wu Y, Zeng B, Su X, et al. Trends in the global, regional, and national burden of testicular cancer from 1990 to 2019: An observational study with 30-year global data. International Journal of Surgery (London, England). 2024;110:4633\u201347.","journal-title":"International Journal of Surgery (London, England)."},{"key":"3849_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102713","volume":"74","author":"P Sun","year":"2024","unstructured":"Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T, et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990\u20132021: Analysis of data from the global burden of disease study 2021. EClinicalMedicine. 2024;74: 102713.","journal-title":"EClinicalMedicine."},{"key":"3849_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","volume":"70","author":"Z Liu","year":"2019","unstructured":"Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, et al. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70:674\u201383.","journal-title":"J Hepatol."},{"key":"3849_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1008953201688","volume":"11","author":"BF Hankey","year":"2000","unstructured":"Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer causes & control: CCC. 2000;11:31\u20135.","journal-title":"Cancer causes & control: CCC."},{"key":"3849_CR38","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al. Guidelines for accurate and transparent health estimates reporting: The GATHER statement. Lancet. 2016;388:e19-23.","journal-title":"Lancet."},{"key":"3849_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335\u201351.","journal-title":"Stat Med."},{"key":"3849_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103359","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, Liu Y-C, Ni Q-Y, Chen Y, Wan C-H, Liu S-Y, et al. Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22: 103359.","journal-title":"Autoimmun Rev."},{"key":"3849_CR41","unstructured":"World Health Organization. Handbook on health inequality monitoring: With a special focus on low- and middle-income countries. World Health Organization; 2013."},{"key":"3849_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102382","volume":"99","author":"F Cao","year":"2024","unstructured":"Cao F, Xu Z, Li X-X, Fu Z-Y, Han R-Y, Zhang J-L, et al. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990\u20132019: A population-based study. Ageing Res Rev. 2024;99: 102382.","journal-title":"Ageing Res Rev."},{"key":"3849_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103326","volume":"22","author":"F Cao","year":"2023","unstructured":"Cao F, He Y-S, Wang Y, Zha C-K, Lu J-M, Tao L-M, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22: 103326.","journal-title":"Autoimmun Rev."},{"key":"3849_CR44","doi-asserted-by":"publisher","DOI":"10.2196\/55327","volume":"10","author":"C Yang","year":"2024","unstructured":"Yang C, Li X, Lv J, Hou M, Zhang R, Guo H, et al. Temporal trends of asthma among children in the western pacific region from 1990 to 2045: Longitudinal observational study. JMIR Public Health and Surveillance. 2024;10: e55327.","journal-title":"JMIR Public Health and Surveillance."},{"key":"3849_CR45","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.eururo.2017.04.010","volume":"72","author":"JP Grummet","year":"2017","unstructured":"Grummet JP, Plass K, N\u2019Dow J. Prostate cancer management in an ageing population. Eur Urol. 2017;72:532\u20133.","journal-title":"Eur Urol."},{"key":"3849_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006477","volume":"12","author":"Y Ding","year":"2016","unstructured":"Ding Y, Wu H, Warden C, Steele L, Liu X, van Iterson M, et al. Gene expression differences in prostate cancers between young and old men. PLoS Genet. 2016;12: e1006477.","journal-title":"PLoS Genet."},{"key":"3849_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41391-020-00314-z","volume":"24","author":"ZR Chalmers","year":"2021","unstructured":"Chalmers ZR, Burns MC, Ebot EM, Frampton GM, Ross JS, Hussain MHA, et al. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. Prostate Cancer Prostatic Dis. 2021;24:558\u201366.","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"3849_CR48","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s12276-024-01291-2","volume":"56","author":"C-R Lee","year":"2024","unstructured":"Lee C-R, Suh J, Jang D, Jin B-Y, Cho J, Lee M, et al. Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma. Exp Mol Med. 2024;56:1807\u201315.","journal-title":"Exp Mol Med."},{"key":"3849_CR49","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/jamainternmed.2017.0340","volume":"177","author":"SA Fedewa","year":"2017","unstructured":"Fedewa SA, Ward EM, Brawley O, Jemal A. Recent patterns of prostate-specific antigen testing for prostate cancer screening in the united states. JAMA Internal Medicine. 2017;177:1040\u20132.","journal-title":"JAMA Internal Medicine."},{"key":"3849_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-5347(05)65382-7","volume":"167","author":"LM Hock","year":"2002","unstructured":"Hock LM, Lynch J, Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the united states: An analysis of surveillance, epidemiology and end results program data. J Urol. 2002;167:57\u201360.","journal-title":"J Urol."},{"key":"3849_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrurol.2016.251","volume":"14","author":"K Fleshner","year":"2017","unstructured":"Fleshner K, Carlsson SV, Roobol MJ. The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA. Nature Reviews Urology. 2017;14:26\u201337.","journal-title":"Nature Reviews Urology."},{"key":"3849_CR52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/bju.13602","volume":"119","author":"H Zargar","year":"2017","unstructured":"Zargar H, van den Bergh R, Moon D, Lawrentschuk N, Costello A, Murphy D. The impact of the united states preventive services task force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in australia. BJU international. 2017;119:110\u20135.","journal-title":"BJU international."},{"key":"3849_CR53","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1136\/gutjnl-2021-325021","volume":"71","author":"X Bai","year":"2022","unstructured":"Bai X, Wei H, Liu W, Coker OO, Gou H, Liu C, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022;71:2439\u201350.","journal-title":"Gut."},{"key":"3849_CR54","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.juro.2016.05.082","volume":"196","author":"J Lara","year":"2016","unstructured":"Lara J, Brunson A, Keegan THM, Malogolowkin M, Pan C-X, Yap S, et al. Determinants of survival for adolescents and young adults with urothelial bladder cancer: Results from the california cancer registry. J Urol. 2016;196:1378\u201382.","journal-title":"J Urol."},{"key":"3849_CR55","doi-asserted-by":"crossref","unstructured":"Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T, et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990\u20132021: analysis of data from the global burden of disease study 2021. eClinicalMedicine. 2024;74:102713.","DOI":"10.1016\/j.eclinm.2024.102713"},{"key":"3849_CR56","doi-asserted-by":"crossref","unstructured":"Barry KH, Martinsen JI, Alavanja MCR, Andreotti G, Blair A, Hansen J, et al. Risk of early-onset prostate cancer associated with occupation in the nordic countries. European Journal of Cancer (Oxford, England: 1990). 2017;87:92\u2013100.","DOI":"10.1016\/j.ejca.2017.09.023"},{"key":"3849_CR57","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/S0007114509993291","volume":"103","author":"A Lophatananon","year":"2010","unstructured":"Lophatananon A, Archer J, Easton D, Pocock R, Dearnaley D, Guy M, et al. Dietary fat and early-onset prostate cancer risk. Br J Nutr. 2010;103:1375\u201380.","journal-title":"Br J Nutr."},{"key":"3849_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030361","volume":"8","author":"CH Pernar","year":"2018","unstructured":"Pernar CH, Ebot EM, Wilson KM, Mucci LA. The epidemiology of prostate cancer. Cold Spring Harbor Perspectives in Medicine. 2018;8: a030361.","journal-title":"Cold Spring Harbor Perspectives in Medicine."},{"key":"3849_CR59","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","volume":"20","author":"LMC van Hoogstraten","year":"2023","unstructured":"van Hoogstraten LMC, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: Challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023;20:287\u2013304.","journal-title":"Nat Rev Clin Oncol."},{"key":"3849_CR60","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, Screening, and Prevention of Bladder Cancer. European Urology Oncology. 2022;5:628\u201339.","journal-title":"European Urology Oncology."},{"key":"3849_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2013.284692","volume":"311","author":"M Ng","year":"2014","unstructured":"Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012. Jama. 2014;311:183\u201392.","journal-title":"Jama."},{"key":"3849_CR62","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1464-410X.2010.09622.x","volume":"107","author":"S Salem","year":"2011","unstructured":"Salem S, Mitchell RE, El-Alim El-Dorey A, Smith JA, Barocas DA. Successful control of schistosomiasis and the changing epidemiology of bladder cancer in egypt. BJU international. 2011;107:206\u201311.","journal-title":"BJU international."},{"key":"3849_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105360","volume":"108","author":"C Deng","year":"2024","unstructured":"Deng C, Zhu J, Fang Z, Yang Y, Zhao Q, Zhang Z, et al. Identification and analysis of microplastics in para-tumor and tumor of human prostate. EBioMedicine. 2024;108: 105360.","journal-title":"EBioMedicine."},{"key":"3849_CR64","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1038\/s41467-024-48857-2","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Deng Z, Soerensen SJC, Kachuri L, Cardenas A, Graff RE, et al. Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence. Nat Commun. 2024;15:5116.","journal-title":"Nat Commun."},{"key":"3849_CR65","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1007\/s00345-023-04546-1","volume":"41","author":"NA Bandara","year":"2023","unstructured":"Bandara NA, Zhou XR, Alhamam A, Black PC, St-Laurent M-P. The genitourinary impacts of electronic cigarette use: A systematic review of the literature. World J Urol. 2023;41:2637\u201346.","journal-title":"World J Urol."},{"issue":"134","key":"3849_CR66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/oxfordjournals.aje.a116143","volume":"1991","author":"R Doll","year":"1991","unstructured":"Doll R, Progress against cancer: An epidemiologic assessment. The,. john C. Cassel memorial lecture Am J Epidemiol. 1991;1991(134):675\u201388.","journal-title":"Cassel memorial lecture. Am J Epidemiol."},{"key":"3849_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11764-021-01006-w","volume":"16","author":"T Michaeli","year":"2022","unstructured":"Michaeli T, Michaeli D. Prostate cancer follow-up costs in germany from 2000 to 2015. Journal of Cancer Survivorship: Research and Practice. 2022;16:86\u201394.","journal-title":"Journal of Cancer Survivorship: Research and Practice."},{"key":"3849_CR68","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10552-007-9083-8","volume":"19","author":"R Etzioni","year":"2008","unstructured":"Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer causes & control: CCC. 2008;19:175\u201381.","journal-title":"Cancer causes & control: CCC."},{"key":"3849_CR69","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1186\/s12889-023-16677-6","volume":"23","author":"N Sandstr\u00f6m","year":"2023","unstructured":"Sandstr\u00f6m N, Johansson M, Jekunen A, Anders\u00e9n H. Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research. BMC public health. 2023;23:1722.","journal-title":"BMC public health."},{"key":"3849_CR70","doi-asserted-by":"crossref","unstructured":"Teoh JY-C, Huang J, Ko WY-K, Lok V, Choi P, Ng C-F, et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. Eur Urol. 2020;78:893\u2013906.","DOI":"10.1016\/j.eururo.2020.09.006"},{"key":"3849_CR71","doi-asserted-by":"crossref","unstructured":"Guadamuz JS, Wang X, Ryals CA, Miksad RA, Snider J, Walters J, et al. Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022. JNCI Cancer Spectrum. 2023;7:pkad058.","DOI":"10.1093\/jncics\/pkad058"},{"key":"3849_CR72","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/ijc.33114","volume":"147","author":"J Lortet-Tieulent","year":"2020","unstructured":"Lortet-Tieulent J, Georges D, Bray F, Vaccarella S. Profiling global cancer incidence and mortality by socioeconomic development. Int J Cancer. 2020;147:3029\u201336.","journal-title":"Int J Cancer."},{"key":"3849_CR73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2018.09.035","volume":"75","author":"Z Klaassen","year":"2019","unstructured":"Klaassen Z, Sayyid RK, Wallis CJD. Lessons learned from the global epidemiology of kidney cancer: A refresher in epidemiology 101. Eur Urol. 2019;75:85\u20137.","journal-title":"Eur Urol."},{"key":"3849_CR74","unstructured":"GBD 2019 Human Resources for Health Collaborators. Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: A systematic analysis for the global burden of disease study 2019. Lancet (London, England). 2022;399:2129\u201354."},{"key":"3849_CR75","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1200\/GO.20.00527","volume":"7","author":"A Carneiro","year":"2021","unstructured":"Carneiro A, Racy D, Bacchi CE, Leite KRM, Filippi RZ, Martins IAF, et al. Consensus on screening, diagnosis, and staging tools for prostate cancer in developing countries: A report from the first prostate cancer consensus conference for developing countries (PCCCDC). JCO global oncology. 2021;7:516\u201322.","journal-title":"JCO global oncology."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03849-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03849-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03849-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:02:37Z","timestamp":1748682157000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03849-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03849-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research is based on and strictly adheres to the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Given that the data obtained from the GBD 2021 are publicly available and have been de-identified, this study does not require participants to provide informed consent or ethical approval from an institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}